Trending...
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- Gabby Press Earns High Praise From Feathered Quill About the Unregulated Dangers of Second Generation Corporate AI
Today, Governor Roy Cooper announced that Audentes Therapeutics, a genetic medicines company, will create 209 new jobs in Lee County, investing $109 million to locate a manufacturing facility in Sanford.
"With our powerhouse research centers and highly-skilled workforce, biotech pioneers recognize North Carolina's role as a leader in the life sciences," said Governor Cooper. "Lee County is a perfect fit for Audentes as they seek to become a global leader in genetic medicines."
An Astellas company, Audentes Therapeutics focuses on developing and commercializing innovative genetic medicines that can offer transformative benefits to patients. Audentes will develop a 135,000 square foot, state-of-the-art, large-scale gene therapy manufacturing facility in Sanford. The initial phase of the capital investment is planned to occur over approximately 18 months, with the plant expected to become operational in 2021. The remaining investment will take place over two additional planned expansion phases.
"Our investment in internal large-scale manufacturing has always been a cornerstone of our strategy to develop and ultimately deliver our important genetic medicines to patients as rapidly as possible. This new facility in Sanford will support the next phase of our growth as we establish a robust, global supply chain and expand our therapeutic and geographic scope as a part of the Astellas group of companies," stated Natalie Holles, President and Chief Executive Officer of Audentes. "We are excited to join the vibrant biopharmaceutical research and manufacturing community that the state of North Carolina has established."
More on ncarol.com
"Audentes Therapeutics is joining one of the nation's top life science clusters," said North Carolina Commerce Secretary Anthony M. Copeland. "North Carolina has the largest biomanufacturing workforce in the nation and a growing concentration of gene therapy scientists, researchers and workers."
The North Carolina Department of Commerce led the state's support for the company's decision.
The average for all new positions could reach up to $83,900. The current average annual wage in Lee County of $41,784.
Audentes' project in North Carolina will be facilitated, in part, by a Job Development Investment Grant (JDIG) approved by the state's Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state's economy by nearly $1.4 billion. Using a formula that takes into account the new tax revenues generated by the 209 new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $3,725,100, spread over 12 years. State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant's reimbursement payments to a given company.
More on ncarol.com
Because Audentes chose to locate in Lee County, classified by the state's economic tier system as Tier 2, the company's JDIG agreement also calls for moving as much as $414,000 into the state's Industrial Development Fund – Utility Account. The Utility Account helps rural communities finance necessary infrastructure upgrades to attract future business. Even when new jobs are created in a Tier 2 county such as Lee, the new tax revenue generated through JDIG grants helps more economically challenged communities elsewhere in the state. More information on the state's economic tier designations is available here.
"This is an exciting day for Lee County and the City of Sanford because this business is an important part of the biotechnology industry, creating hundreds of jobs and contributing millions of dollars to our local economy," said N.C. Senator Jim Burgin.
"Audentes' new jobs and investment are great wins for the entire state," said N.C. Representative John Sauls. "North Carolina has a strong pipeline of biopharmaceutical talent and a business climate to support their future growth and success."
In addition to N.C. Commerce and the Economic Development Partnership of North Carolina, other key partners in the project include the North Carolina General Assembly, North Carolina Community College System, Lee County, Sanford Area Growth Alliance, City of Sanford, and North Carolina Biotechnology Center.
"With our powerhouse research centers and highly-skilled workforce, biotech pioneers recognize North Carolina's role as a leader in the life sciences," said Governor Cooper. "Lee County is a perfect fit for Audentes as they seek to become a global leader in genetic medicines."
An Astellas company, Audentes Therapeutics focuses on developing and commercializing innovative genetic medicines that can offer transformative benefits to patients. Audentes will develop a 135,000 square foot, state-of-the-art, large-scale gene therapy manufacturing facility in Sanford. The initial phase of the capital investment is planned to occur over approximately 18 months, with the plant expected to become operational in 2021. The remaining investment will take place over two additional planned expansion phases.
"Our investment in internal large-scale manufacturing has always been a cornerstone of our strategy to develop and ultimately deliver our important genetic medicines to patients as rapidly as possible. This new facility in Sanford will support the next phase of our growth as we establish a robust, global supply chain and expand our therapeutic and geographic scope as a part of the Astellas group of companies," stated Natalie Holles, President and Chief Executive Officer of Audentes. "We are excited to join the vibrant biopharmaceutical research and manufacturing community that the state of North Carolina has established."
More on ncarol.com
- Santa Your Way Announces Official 2026 Q4 Holiday Tour: Booking Open For Santa, The 5-star Grinch, And Dual Character Experiences Nationwide
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
- Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
"Audentes Therapeutics is joining one of the nation's top life science clusters," said North Carolina Commerce Secretary Anthony M. Copeland. "North Carolina has the largest biomanufacturing workforce in the nation and a growing concentration of gene therapy scientists, researchers and workers."
The North Carolina Department of Commerce led the state's support for the company's decision.
The average for all new positions could reach up to $83,900. The current average annual wage in Lee County of $41,784.
Audentes' project in North Carolina will be facilitated, in part, by a Job Development Investment Grant (JDIG) approved by the state's Economic Investment Committee earlier today. Over the course of the 12-year term of this grant, the project is estimated to grow the state's economy by nearly $1.4 billion. Using a formula that takes into account the new tax revenues generated by the 209 new jobs, the JDIG agreement authorizes the potential reimbursement to the company of up to $3,725,100, spread over 12 years. State payments only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant's reimbursement payments to a given company.
More on ncarol.com
- Can Government Operate Better Through Innovation?
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- She Writes Python and Produces Music. KayeDinero Has a Question About AI Artists
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
- There and Back comes to Hillsborough
Because Audentes chose to locate in Lee County, classified by the state's economic tier system as Tier 2, the company's JDIG agreement also calls for moving as much as $414,000 into the state's Industrial Development Fund – Utility Account. The Utility Account helps rural communities finance necessary infrastructure upgrades to attract future business. Even when new jobs are created in a Tier 2 county such as Lee, the new tax revenue generated through JDIG grants helps more economically challenged communities elsewhere in the state. More information on the state's economic tier designations is available here.
"This is an exciting day for Lee County and the City of Sanford because this business is an important part of the biotechnology industry, creating hundreds of jobs and contributing millions of dollars to our local economy," said N.C. Senator Jim Burgin.
"Audentes' new jobs and investment are great wins for the entire state," said N.C. Representative John Sauls. "North Carolina has a strong pipeline of biopharmaceutical talent and a business climate to support their future growth and success."
In addition to N.C. Commerce and the Economic Development Partnership of North Carolina, other key partners in the project include the North Carolina General Assembly, North Carolina Community College System, Lee County, Sanford Area Growth Alliance, City of Sanford, and North Carolina Biotechnology Center.
0 Comments
Latest on ncarol.com
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- Notaron Expands Online Notarization Access Following Wisconsin Approval
- Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
- Greater Charlotte ASTA Celebrates 2026 Queen City Travel Summit
- The Social Capital Revolution Comes to Phoenix!
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
- Bettingbladet releases H1 2026 report on the Swedish online gambling market
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- Google AI Says KayeDinero Isn't the Greatest Female Producer. She Asks: Who Decides?
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
- From Michael Jackson to Drake: The Artists Who Shaped KayeDinero's Sound
- L-Tron to Attend the 2026 NC, GA, TN, SC Joint Regional IAI Conference
- "Kulture Metrics" Isn't Just an Album Title: KayeDinero Connects Music, Markets and Code
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran